PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 134 filers reported holding PDL BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $40,000 | -46.7% | 12,280 | -48.6% | 0.00% | -100.0% |
| Q2 2019 | $75,000 | +63.0% | 23,873 | +92.8% | 0.00% | – |
| Q1 2019 | $46,000 | -24.6% | 12,385 | -41.1% | 0.00% | -100.0% |
| Q4 2018 | $61,000 | +103.3% | 21,025 | +61.9% | 0.00% | – |
| Q2 2018 | $30,000 | -53.8% | 12,985 | -41.5% | 0.00% | – |
| Q1 2018 | $65,000 | -8.5% | 22,198 | -14.7% | 0.00% | -100.0% |
| Q4 2017 | $71,000 | +77.5% | 26,027 | +59.4% | 0.00% | -75.0% |
| Q2 2017 | $40,000 | -73.0% | 16,325 | -75.0% | 0.01% | -72.4% |
| Q1 2017 | $148,000 | +31.0% | 65,417 | +81.3% | 0.03% | -52.5% |
| Q2 2016 | $113,000 | – | 36,084 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |